(3Z)-3-{[(3,4-dichlorophenyl)methoxy]imino}-1-[(2,4-dichlorophenyl)methyl]-2,3-dihydro-1H-indol-2-one

Catalog No. :
ACACKF028
CAS No. :
303996-95-4
Molecular Formula :
C22H14Cl4N2O2
Molecular Weight :
480.18

IUPAC Name:(Z)-1-(2,4-dichlorobenzyl)-3-(((3,4-dichlorobenzyl)oxy)imino)indolin-2-one

(3Z)-3-{[(3,4-dichlorophenyl)methoxy]imino}-1-[(2,4-dichlorophenyl)methyl]-2,3-dihydro-1H-indol-2-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(3Z)-3-{[(3,4-dichlorophenyl)methoxy]imino}-1-[(2,4-dichlorophenyl)methyl]-2,3-dihydro-1H-indol-2-one
IUPAC Name(Z)-1-(2,4-dichlorobenzyl)-3-(((3,4-dichlorobenzyl)oxy)imino)indolin-2-one
MDL No.MFCD00141584
Molecular FormulaC22H14Cl4N2O2
Molecular Weight480.18
SMILESO=C1N(CC2=CC=C(Cl)C=C2Cl)C3=C(C=CC=C3)/C1=N/OCC4=CC=C(Cl)C(Cl)=C4
InChI KeyQYBBZQWITJAMKG-MEFGMAGPSA-N
Synonym1-(2,4-DICHLOROBENZYL)-1H-INDOLE-2,3-DIONE 3-[O-(3,4-DICHLOROBENZYL)OXIME];(3Z)-3-{[(3,4-dichlorophenyl)methoxy]imino}-1-[(2,4-dichlorophenyl)methyl]-2,3-dihydro-1H-indol-2-one;1H-Indole-2,3-dione, 1-[(2,4-dichlorophenyl)methyl]-, 3-[O-[(3,4-dichlorophenyl)methyl]oxime]
CAS No.303996-95-4

Synthetic Route by SureRoute

1. ACACKF028 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOWGM620 route compound structure diagram
    ACOWGM62020443-99-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACACKF028 route product structure diagram
    ACACKF028303996-95-4
Inquiry

2. ACACKF028 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACACKF028 route product structure diagram
    ACACKF028303996-95-4
Inquiry

Comments (0)